4//SEC Filing
Unkart Edward W 4
Accession 0001209191-09-032886
CIK 0001040666other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:52 PM ET
Size
19.7 KB
Accession
0001209191-09-032886
Insider Transaction Report
Form 4
Unkart Edward W
Director
Transactions
- Disposition to Issuer
Stock Options (right to buy)
2009-06-17−9,000→ 0 totalExercise: $17.05Exp: 2018-05-23→ Common Stock (9,000 underlying) - Disposition from Tender
Common Stock
2009-06-17$29.00/sh−6,000$174,000→ 5,000 total - Disposition to Issuer
Stock Options (right to buy)
2009-06-17−20,000→ 0 totalExercise: $15.00Exp: 2014-10-25→ Common Stock (20,000 underlying) - Disposition to Issuer
Common Stock
2009-06-17$29.00/sh−1,250$36,250→ 0 total - Disposition to Issuer
Stock Options (right to buy)
2009-06-17−10,000→ 0 totalExercise: $7.17Exp: 2016-05-25→ Common Stock (10,000 underlying)
Footnotes (7)
- [F1]These shares were tendered to Covidien Delaware Corp. (the "Purchaser") pursuant to Purchaser's offer to purchase all of the outstanding shares of VNUS Medical Technologies, Inc. (the "Issuer") at a cash purchase price of $29.00 per share, without interest thereon, and less any applicable withholding taxes, subject to the terms described in the Offer to Purchase for Cash filed with the Securities and Exchange Commission on May 18, 2009 (the "Tender Offer") and the Agreement and Plan of Merger, dated as of May 7, 2009, by and among Covidien Group S.a.r.l., the Purchaser and the Issuer (the "Merger"). Such shares were purchased by the Purchaser pursuant to the Tender Offer on June 17, 2009.
- [F2]Represents restricted stock units that vested and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes). The remaining 3,750 restricted stock units, which were granted to the Reporting Person on May 20, 2009, were canceled for no consideration in connection with the Merger.
- [F3]These options, which were fully vested at the effective time of the Merger, were canceled at the effective time of the Merger in exchange for a cash payment of $107,550.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F4]These options, which were fully vested at the effective time of the Merger, were canceled at the effective time of the Merger in exchange for a cash payment of $151,110.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F5]These options, which were fully vested at the effective time of the Merger, were canceled at the effective time of the Merger in exchange for a cash payment of $218,300.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F6]These options, which were fully vested at the effective time of the Merger, were canceled at the effective time of the Merger in exchange for a cash payment of $182,600.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F7]These options, which were fully vested at the effective time of the Merger, were canceled at the effective time of the Merger in exchange for a cash payment of $280,000.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
Documents
Issuer
VNUS MEDICAL TECHNOLOGIES INC
CIK 0001040666
Entity typeother
Related Parties
1- filerCIK 0001306267
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 8:52 PM ET
- Size
- 19.7 KB